{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-349197","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2026-08-13T20:11:12+00:00","discovered_at":"2026-08-13T20:13:00.258618+00:00","generated_at":"2026-08-13T20:13:20.626359+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rani Therapeutics Q2 2026 net loss $8.4M; RT-114 oral bioavailability >150% vs subcutaneous","bullets":["RT-114 Phase 1a: oral bioavailability >150% vs matched subcutaneous PG-102; no serious adverse events.","First participants dosed in Phase 1a expansion cohort; Phase 1b in obesity expected by end 2026.","Completed $20M registered direct offering; cash $53.4M as of June 30, 2026, sufficient through 2027.","New PegBio collaboration to explore oral delivery of obesity/metabolic molecules via RaniPill.","Appointed Nicholas Maestas as CFO and Michelle Gilson to Board; net loss $8.4M vs $11.2M YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-349197","json":"https://secwatch.observer/filing/0001193125-26-349197.json","markdown":"https://secwatch.observer/filing/0001193125-26-349197.md","text":"https://secwatch.observer/filing/0001193125-26-349197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526349197/0001193125-26-349197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526349197/rani-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:13:20.626359+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}